why choose us

First received: May 18, 2023

Clinical Trial: Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer - the FLU-IMMUNE Trial.

Brief Summary: Immune checkpoint inhibitor (ICI) treatment has produced striking results in patients with colorectal cancer (CRC) of the subtype deficient mismatch repair (dMMR).The majority of patients, however, have proficient MMR (pMMR) tumors, with limited effect of ICIs.The key difference between dMMR and pMMR tumors is the infiltration of cytotoxic T-cells.dMMR tumors have increased infiltration and thus increased efficacy from ICI treatment.The investigators conducted a proof of concept study where the investigators…

Read more